YES Securities' research report on ICICI Prudential Life
The sluggishness in retail protection continued on account of changes in guidelines and continued reluctance of potential customers to carry out medical testing. The share of annuity products in new business received premium has risen to 20.1% in 1HFY22 compared with 15.2% in 1HFY21 due to a 95% YoY rise. IPRU continues to invest in all channels and is seeing good growth in agency, direct channel including proprietary sales and online channel.
Outlook
We maintain ‘Buy’ rating on IPRU with a revised price target of Rs 836.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
